Broad Gets Massachusetts Approval to Sequence Clinical Samples under CLIA | GenomeWeb

NEW YORK (GenomeWeb News) – The Broad Institute has obtained approval from the state of Massachusetts to start processing clinical samples under CLIA, the institute said today.

After passing inspection by the state, the Broad has completed "a critical step on the path toward establishing a Clinical Research Sequencing Platform," according to a statement from the institute, and can now perform clinical testing, including sequencing, on patient samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.